Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02053480 · ClinicalTrials.gov registry record

Pyruvate Kinase Deficiency Natural History Study

A clinical trial of Pyruvate Kinase Deficiency and Congenital Non-Spherocytic Hemolytic Anemia, sponsored by Boston Children's Hospital.

Completed
Registry status
254
Enrollment target
20
Study locations

NCT02053480 is a study of Pyruvate Kinase Deficiency and Congenital Non-Spherocytic Hemolytic Anemia that has completed, run by Boston Children's Hospital. The registered enrollment target is 254 participants. The trial reports 20 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02053480, a study of Pyruvate Kinase Deficiency and Congenital Non-Spherocytic Hemolytic Anemia, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
254 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to describe the range and incidence of symptoms, treatments, and complications related to pyruvate kinase deficiency (PKD). Eligible patients are those of all ages with known PKD or with a hemolytic anemia and a family member with PKD. The study will collect retrospective medical history, routine clinical care data, and quality of life measures at baseline and annually for patients with PKD.

Study Locations (20)

Massachusetts

  • Boston Children's Hospital - Boston
  • University of Massachusetts Medical Center - Worcester

Ohio

  • Nationwide Children's Hospital - Columbus
  • DDC Clinic for Special Needs Children - Middlefield

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia
  • Central Pennsylvania Clinic - Strasburg

Arizona

  • Phoenix Children's Hospital - Phoenix

California

  • Stanford University - Palo Alto

Georgia

  • Children's Hospital of Atlanta - Atlanta

Illinois

  • Lurie Children's Hospital - Chicago

Michigan

  • Wayne State University School of Medicine - Detroit

Trial Details

FieldValue
Enrollment Target 254 participants
Start Date 2013-12
Est. Completion 2020-05

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT02053480

The ClinicalTrials.gov registry entry for NCT02053480 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pyruvate Kinase Deficiency appearing as the primary indexed condition, and to 0 interventions.

NCT02053480 reports 20 study locations spanning 17 distinct geographic areas - top geographies include Massachusetts, Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02053480 about?

NCT02053480 is a clinical study titled "Pyruvate Kinase Deficiency Natural History Study". The purpose of this study is to describe the range and incidence of symptoms, treatments, and complications related to pyruvate kinase deficiency (PKD). Eligible patients are those of all ages with known PKD or with a hemolytic anemia and a family member with PKD. The study will collect retrospectiv...

What is the current status of trial NCT02053480?

This trial is currently completed. The enrollment target is 254 participants. The study started on 2013-12. Estimated completion is 2020-05.

What conditions does trial NCT02053480 study?

This clinical trial studies the following conditions: Pyruvate Kinase Deficiency, Congenital Non-Spherocytic Hemolytic Anemia.

Who is sponsoring clinical trial NCT02053480?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02053480 being conducted?

This trial has 20 study locations across Arizona, California, Georgia, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pyruvate Kinase Deficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.